Work With Us
A quiet, deliberate ask
Build a forest
with us.
We're seeking the right partners to bring TerraNova into a lab. This page lays out what we need, what we offer, and how to get in touch.
We're seeking the right partners to bring TerraNova into a lab. This page lays out what we need, what we offer, and how to get in touch.
Every gene edit has been mapped. Every species selected. Every climate zone modeled. What remains is the most important step — bringing our design into living form.
We're raising a seed round and seeking partnerships with research institutions that have the lab infrastructure to support early-stage plant biotech work. We can move quickly with relatively modest capital. We are deliberately not optimizing for valuation — we are optimizing for the right partners.
We are raising a seed round to fund 18 months of lab work and team expansion. We're looking for capital that understands long timelines and climate-aligned outcomes.
Universities, contract labs, and existing biotech facilities with plant-tissue capabilities — we'd love to talk about hosted research arrangements or collaborative partnerships.
Foundations, mission-driven donors, and people with relevant networks. Not every contribution is capital — sometimes the right introduction is worth more.
A seed round sized to fund 18 months of lab work, modest team expansion, and the first round of in-vitro experiments. Specific figures are shared with serious inquiries — please reach out.
We're in early conversations with several research institutions and contract labs. Final arrangements depend on the funding round closing and on choosing the right collaborators. If your institution has plant-tissue capabilities, we'd love to talk.
Our work uses CRISPR-based edits that do not introduce foreign DNA, which in most jurisdictions falls under a substantially lighter regulatory regime than transgenic approaches. We're tracking this closely and working with policy advisors.
Currently a research initiative. We're evaluating structures — including hybrid models — and the right entity choice depends in part on the partners we work with. Open to conversations about this.
Seriously, and at the center of the work. Our edits target genes already present in native species, which substantially reduces the risk of unintended ecological effects. We're committed to extensive containment during lab work and gradual, monitored field trials before any scale planting.